Craft

Sagent Pharmaceuticals

Revenue

$318.3 M

FY, 2015

Sagent Pharmaceuticals Summary

Company Summary

Overview
Sagent Pharmaceuticals is focused on developing, manufacturing, sourcing and marketing pharmaceutical products. The Company offers its customers a broad range of products across anti-infective, oncology and critical care indications in a variety of presentations, including single- and multi-dose vials and ready-to-use pre-filled syringes and premix bags. Sagent generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience.
Type
Subsidiary
Status
Active
Founded
2006
HQ
Schaumburg, IL, US | view all locations
Website
http://www.sagentpharma.com
Cybersecurity rating
Sectors

Key People

  • Jerry Webb

    Jerry Webb, Executive Vice President, Operations

    • Don Bullock

      Don Bullock, Executive Vice President, Sales and National Accounts

      • Peter Kaemmerer

        Peter Kaemmerer, CEO

        LocationsView all

        1 location detected

        • Schaumburg, IL HQ

          United States

          1901 N Roselle Rd

        Sagent Pharmaceuticals Financials

        Summary Financials

        Revenue (Q2, 2016)
        $71.7M
        Gross profit (Q2, 2016)
        $17.4M
        Net income (Q2, 2016)
        ($515.0K)
        Cash (Q2, 2016)
        $15.5M
        EBIT (Q2, 2016)
        ($469.0K)

        Footer menu